134 related articles for article (PubMed ID: 12368330)
1. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
2. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
Garber ME; Wei P; KewalRamani VN; Mayall TP; Herrmann CH; Rice AP; Littman DR; Jones KA
Genes Dev; 1998 Nov; 12(22):3512-27. PubMed ID: 9832504
[TBL] [Abstract][Full Text] [Related]
3. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.
Michels AA; Nguyen VT; Fraldi A; Labas V; Edwards M; Bonnet F; Lania L; Bensaude O
Mol Cell Biol; 2003 Jul; 23(14):4859-69. PubMed ID: 12832472
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
[TBL] [Abstract][Full Text] [Related]
5. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
Zhu Y; Pe'ery T; Peng J; Ramanathan Y; Marshall N; Marshall T; Amendt B; Mathews MB; Price DH
Genes Dev; 1997 Oct; 11(20):2622-32. PubMed ID: 9334325
[TBL] [Abstract][Full Text] [Related]
6. TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication.
Richter S; Ping YH; Rana TM
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7928-33. PubMed ID: 12048247
[TBL] [Abstract][Full Text] [Related]
7. Identification of multiple cyclin subunits of human P-TEFb.
Peng J; Zhu Y; Milton JT; Price DH
Genes Dev; 1998 Mar; 12(5):755-62. PubMed ID: 9499409
[TBL] [Abstract][Full Text] [Related]
8. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro.
Mancebo HS; Lee G; Flygare J; Tomassini J; Luu P; Zhu Y; Peng J; Blau C; Hazuda D; Price D; Flores O
Genes Dev; 1997 Oct; 11(20):2633-44. PubMed ID: 9334326
[TBL] [Abstract][Full Text] [Related]
9. The TAR binding dynamics and its implication in Tat degradation mechanism.
Ning S; Zeng C; Zeng C; Zhao Y
Biophys J; 2021 Dec; 120(23):5158-5168. PubMed ID: 34762866
[TBL] [Abstract][Full Text] [Related]
10. P-TEFb kinase recruitment and function at heat shock loci.
Lis JT; Mason P; Peng J; Price DH; Werner J
Genes Dev; 2000 Apr; 14(7):792-803. PubMed ID: 10766736
[TBL] [Abstract][Full Text] [Related]
11. HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV Therapies.
Asamitsu K; Fujinaga K; Okamoto T
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673219
[TBL] [Abstract][Full Text] [Related]
12. Intracellular delivery of p53 fused to the basic domain of HIV-1 Tat.
Ryu J; Lee HJ; Kim KA; Lee JY; Lee KS; Park J; Choi SY
Mol Cells; 2004 Apr; 17(2):353-9. PubMed ID: 15179054
[TBL] [Abstract][Full Text] [Related]
13. Human GLI-2 is a tat activation response element-independent Tat cofactor.
Browning CM; Smith MJ; Clark NM; Lane BR; Parada C; Montano M; KewalRamani VN; Littman DR; Essex M; Roeder RG; Markovitz DM
J Virol; 2001 Mar; 75(5):2314-23. PubMed ID: 11160734
[TBL] [Abstract][Full Text] [Related]
14. Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages.
Ramakrishnan R; Chiang K; Liu H; Budhiraja S; Donahue H; Rice AP
Biology (Basel); 2012 Jun; 1(1):94-115. PubMed ID: 24832049
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting "block and lock" treatment strategies.
Horvath RM; Brumme ZL; Sadowski I
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0107223. PubMed ID: 38319085
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.
Khatkar P; Mensah G; Ning S; Cowen M; Kim Y; Williams A; Abulwerdi FA; Zhao Y; Zeng C; Le Grice SFJ; Kashanchi F
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256867
[TBL] [Abstract][Full Text] [Related]
17. Structure of a low-population binding intermediate in protein-RNA recognition.
Borkar AN; Bardaro MF; Camilloni C; Aprile FA; Varani G; Vendruscolo M
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7171-6. PubMed ID: 27286828
[TBL] [Abstract][Full Text] [Related]
18. Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex.
Lin R; Yang J; Liu T; Wang M; Ke C; Luo C; Lin J; Li J; Lin H
Chem Biodivers; 2023 Aug; 20(8):e202300769. PubMed ID: 37349855
[TBL] [Abstract][Full Text] [Related]
19. A kinase-independent activity of Cdk9 modulates glucocorticoid receptor-mediated gene induction.
Zhu R; Lu X; Pradhan M; Armstrong SP; Storchan GB; Chow CC; Simons SS
Biochemistry; 2014 Mar; 53(11):1753-67. PubMed ID: 24559102
[TBL] [Abstract][Full Text] [Related]
20. GigaAssay - An adaptable high-throughput saturation mutagenesis assay platform.
Benjamin R; Giacoletto CJ; FitzHugh ZT; Eames D; Buczek L; Wu X; Newsome J; Han MV; Pearson T; Wei Z; Banerjee A; Brown L; Valente LJ; Shen S; Deng HW; Schiller MR
Genomics; 2022 Jul; 114(4):110439. PubMed ID: 35905834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
